Financhill
Buy
78

ALGS Quote, Financials, Valuation and Earnings

Last price:
$10.64
Seasonality move :
-0.28%
Day range:
$9.84 - $10.26
52-week range:
$3.76 - $46.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
33.71x
P/B ratio:
0.86x
Volume:
33.8K
Avg. volume:
81.5K
1-year change:
-64.28%
Market cap:
$61.5M
Revenue:
$3.9M
EPS (TTM):
-$19.76

Earnings Data

Next earnings date for ALGS
Mar 09
2026
Most recent earnings per share
-$3.04
Missed by $1.03
(Nov 6/2025)
Consensus Estimate
-$2.01
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALGS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/09/2026 Q4 $266.7K -- -- -$2.33 --
11/06/2025 Q3 $500K $741K -$3.04 -$2.01 -$1.03
08/06/2025 Q2 $433.3K $965K -$1.53 -$2.54 $1.00
05/06/2025 Q1 $500K $311K -$2.11 -$3.15 $1.04
03/10/2025 Q4 $433.3K $629K -$13.08 -$3.67 -$9.41
11/06/2024 Q3 $333.3K $1.3M -$3.07 -$1.33 -$1.75
08/06/2024 Q2 -- $1.1M $0.81 -$4.00 $4.81
05/07/2024 Q1 -- $986K -$5.58 -$4.75 -$0.83
03/12/2024 Q4 $1.6M $2.7M -$5.50 -$6.75 $1.25
11/02/2023 Q3 $2.5M $3.2M -- -$11.88 --
08/03/2023 Q2 -- $6.9M -- -- --
05/04/2023 Q1 -- $2.7M -- -- --
03/09/2023 Q4 -- $3.5M -- -- --
11/02/2022 Q3 -- $4.1M -- -- --
08/04/2022 Q2 -- $3.7M -- -- --
05/04/2022 Q1 -- $2.6M -- -- --
03/10/2022 Q4 -- $367K -- -- --
11/04/2021 Q3 -- $1.5M -- -- --
08/05/2021 Q2 -- $1.5M -- -- --
05/10/2021 Q1 -- $910K -- -- --
03/23/2021 Q4 -- -- -- -- --
11/25/2020 Q3 -- -- -- -- --
06/30/2020 Q2 -- -- -- -- --
03/31/2020 Q1 -- -- -$22.83 -- --
12/31/2019 Q4 -- -- -$20.73 -- --
09/30/2019 Q3 -- -- -$16.02 -- --

Aligos Therapeutics, Inc. Earnings Questions

  • How Much did Aligos Therapeutics, Inc. Generate in Revenue Last Quarter?

    Aligos Therapeutics, Inc. reported $741K worth of top line sales in its most recent quarter.

  • Did Aligos Therapeutics, Inc. Beat Earnings Last Quarter?

    Aligos Therapeutics, Inc. announced earnings per share of -$3.04 which represents a miss of analyst forecast a -$2.01 per share.

  • Is Aligos Therapeutics, Inc. Profitable?

    Aligos Therapeutics, Inc. reported $521K that represents $0.05 per share over the last quarter.

  • What is the Analyst Consensus for Aligos Therapeutics, Inc. EPS Next Year?

    Aligos Therapeutics, Inc.'s earnings are forecast to decrease from -$20.94 per share to -$10.36 per share next year representing a decrease of -66.83%.

  • When is Aligos Therapeutics, Inc.'s Earnings Date?

    Aligos Therapeutics, Inc.'s next earnings date is March 9, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 64.76% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.67% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 3.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock